Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 13
2003 10
2004 11
2005 27
2006 24
2007 29
2008 24
2009 23
2010 35
2011 39
2012 49
2013 43
2014 58
2015 60
2016 55
2017 62
2018 69
2019 48
2020 58
2021 65
2022 60
2023 53
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

808 results

Results by year

Filters applied: . Clear all
Page 1
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
Hartner AM, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers MJ, Ferrari MJ, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Karachaliou A, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Minh QT, Vynnycky E, Winter AK, Burrows H, Chen C, Clapham HE, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim JH, Koh J, Lopman BA, Pitzer VE, Tam Y, Lambach P, Sim SY, Woodruff K, Ferguson NM, Trotter CL, Gaythorpe KAM. Hartner AM, et al. Among authors: kim jh. Lancet Glob Health. 2024 Apr;12(4):e563-e571. doi: 10.1016/S2214-109X(23)00603-4. Lancet Glob Health. 2024. PMID: 38485425 Free PMC article.
A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma.
Kim CG, Hong MH, Kim D, Lee BH, Kim H, Ock CY, Kelly G, Bang YJ, Kim G, Lee JE, Kim C, Kim SH, Hong HJ, Park YM, Sim NS, Park H, Park JW, Lee CG, Kim KH, Park G, Jung I, Han D, Kim JH, Cha J, Lee I, Kang M, Song H, Oum C, Kim S, Kim S, Lim Y, Kim-Schulze S, Merad M, Yoon SO, Kim HJ, Koh YW, Kim HR. Kim CG, et al. Among authors: kim jh. Clin Cancer Res. 2024 Mar 8. doi: 10.1158/1078-0432.CCR-23-3249. Online ahead of print. Clin Cancer Res. 2024. PMID: 38457288
Mapping the incidence rate of typhoid fever in sub-Saharan Africa.
Kim JH, Choi J, Kim C, Pak GD, Parajulee P, Haselbeck A, Park SE, Mogasale V, Jeon HJ, Browne AJ, Owusu-Dabo E, Rakotozandrindrainy R, Bassiahi AS, Teferi M, Lunguya-Metila O, Dolecek C, Pitzer VE, Crump JA, Hay SI, Marks F. Kim JH, et al. PLoS Negl Trop Dis. 2024 Feb 26;18(2):e0011902. doi: 10.1371/journal.pntd.0011902. eCollection 2024 Feb. PLoS Negl Trop Dis. 2024. PMID: 38408128 Free PMC article.
Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study.
Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. Kang H, et al. Among authors: kim jh. Lancet Infect Dis. 2024 May;24(5):488-503. doi: 10.1016/S1473-3099(23)00810-1. Epub 2024 Feb 8. Lancet Infect Dis. 2024. PMID: 38342105 Free article.
808 results